TL4: Innovated Design for First Time in Human Study
*Yu Lou, Glaxosmithkline 


In this roundtable session, participates will join the discussion and share information for the FTIH trial design. The focus points of the discussion will include the following aspects: 1) How to identify the right initial doses; 2) how to manage the unexpected results; 3) how to escalate the doses; 4) if we should use Bayesian method to predict the dose and drug exposure; and 5) strategies for dose escaltion trials for more than one drug; 6) any other related topics.